Skip to content

JANS KINESITHERAPIE

Active Private limited companyfounded 2020active for 6 yearsHemelsveldstraat 96, 3570 AlkenKBO/BCE: BE 0744.521.421

Lifetime

6 annual accounts with figures on one time axis
peak of €64,661 in 2025
€64,661▲ 3.7%
peak of €17,519 in 2022
€8,213▲ 57.0%
peak of €64,670 in 2024
€34,397▼ 46.8%
€154,520▲ 23.4%
Board1 name since 2020
1 director
Documentsfilings and deeds
16-06-202645 days before the deadline
2025micro format
Result from €5,232 to €8,213Dividend €38,486Equity from €64,670 to €34,397Debts from €125,255 to €154,520Cash from €43,816 to €67,095

Key points

from the 2025 annual accounts

Equity

€34,397 ▼ 46.8%
64,6702024+8,213Profit-38,486Dividend34,3972025

JANS KINESITHERAPIE paid out €38,486 in dividends. That is 469% of the 2025 profit.

Debts

€154,520 82% of the balance sheet
Financial debts 28%Suppliers 15%Taxes and wages 2%Other 54%

Of this, €97,615 falls due within a year.

Filings

6 annual accounts 3 late
AprilJune31 JulyOctober202020222024

The 2022 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,273 companies had the same profile as JANS KINESITHERAPIE has now. Each dot stands for 9 companies, two years later.

94.6%
were still trading
2.6%
stopped another way
2.5%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,273 companies, not a prediction for JANS KINESITHERAPIE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 02-03-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0744521421
Incorporation Founded by · appointed as director · 100 shares · published on 02-03-2020 · Gazette deed
First establishment Hemelsveldstraat 96, Alken
All 11 events

Comparable companies

same main activity, similar in size and age
Company
JANS KINESITHERAPIE Alken €188,917 €64,661 18.2% -
Move4Change Grimbergen €198,511 €64,691 54.8% -
Coppens-Ommeslag Oostkamp €217,011 €69,331 9.2% -
Podokor Kortrijk €226,199 €66,144 71.2% -
Kinepraktijk Body in Motion Genk €187,906 €58,050 13.8% -
Kinecare Tongeren-Borgloon €156,652 €72,815 30.6% -
HARENMOLEN Tongeren-Borgloon €165,931 €55,939 76.4% -

These companies have the same main activity as JANS KINESITHERAPIE: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €157,000 and €226,000, founded between 2019 and 2021.

Official details

Source: KBO
Status
Active since 27-02-2020Normal situation
Activity
PhysiotherapyNACE 86951and 2 others
Establishment unit
2.300.085.3783570 Alken, since 27-02-2020
Financial year end
31 December
Peppol
Reachable since 05-06-2025
Company details

Annual accounts 2025

≈ €190,000estimated
€188,917▼ 0.5%
≈ 0.2 FTEestimated
Filing
Filed on 16-06-2026, 45 days before the end of the filing period
Financials

Insights on JANS KINESITHERAPIE

JANS KINESITHERAPIE files the micro format. That format states no turnover. The gross margin rose from €49,657 in 2020 to €64,661 in 2025.

The balance sheet grew most from 2021 to 2022 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about JANS KINESITHERAPIE

What is the company number of JANS KINESITHERAPIE?
The company number of JANS KINESITHERAPIE is 0744.521.421. The VAT number is the same number with BE in front: BE 0744.521.421.
Where is JANS KINESITHERAPIE based?
The registered office is at Hemelsveldstraat 96, 3570 Alken.Company details
What does JANS KINESITHERAPIE do?
According to the KBO register, the main activity is physiotherapy (NACE 86951).
What is the legal form of JANS KINESITHERAPIE?
JANS KINESITHERAPIE is a private limited company (BV).
When was JANS KINESITHERAPIE founded?
JANS KINESITHERAPIE was founded on 27-02-2020.
Is JANS KINESITHERAPIE still active?
Yes, JANS KINESITHERAPIE is an active enterprise in the KBO register.
What is the turnover of JANS KINESITHERAPIE?
The turnover in financial year 2025 is about €190,000. This figure is estimated from the gross margin of €64,661 and 31 comparable companies (NACE 869). It probably lies between €120,000 and €280,000.Financials
Is JANS KINESITHERAPIE profitable?
In financial year 2025, JANS KINESITHERAPIE made a profit of €8,213.
Where can I find the annual accounts of JANS KINESITHERAPIE?
JANS KINESITHERAPIE filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of JANS KINESITHERAPIE due?
JANS KINESITHERAPIE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.